Home Cart Sign in  
Chemical Structure| 1256565-36-2 Chemical Structure| 1256565-36-2

Structure of PTC299
CAS No.: 1256565-36-2

Chemical Structure| 1256565-36-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PTC299 is an orally active VEGF mRNA translation inhibitor that selectively inhibits the synthesis of VEGF protein and also inhibits dihydroorotate dehydrogenase (DHODH), with antitumor activity.

Synonyms: Emvododstat

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PTC299

CAS No. :1256565-36-2
Formula : C25H20Cl2N2O3
M.W : 467.34
SMILES Code : [H][C@]1(C2=CC=C(OC)C=C2)C3=C(C4=CC(Cl)=CC=C4N3)CCN1C(OC5=CC=C(Cl)C=C5)=O
Synonyms :
Emvododstat

Safety of PTC299

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of PTC299

DNA
RTK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03761069 Leukemia, Myeloid, Acute|AML PHASE1 TERMINATED 2021-12-28 Rocky Mountain Cancer Center, ... More >>Aurora, Colorado, 80012, United States|Yale University, New Haven, Connecticut, 06510, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Rutgers, Cancer Institute of NJ, New Brunswick, New Jersey, 08903, United States|Columbia, New York, New York, 10032, United States|University of Rochester MC, Rochester, New York, 14642, United States|Duke Cancer Center, Durham, North Carolina, 27710, United States|Gabrail Cancer Center, Canton, Ohio, 44718, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45236, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Rhode Island, Miriam Hospital, Providence, Rhode Island, 02903, United States|SCRI Tennessee Oncology, Nashville, Tennessee, 37203, United States|Texas Oncology, P.A., Austin, Texas, 78705, United States|Texas Oncology, P.A., Fort Worth, Texas, 76104, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Texas Oncology, P.A. - San Antonio Medical Center, San Antonio, Texas, 78240, United States|Swedish Cancer Institute, Seattle, Washington, 91804, United States Less <<
NCT00508586 Metastatic Breast Cancer PHASE1 COMPLETED 2025-03-12 Indiana University Simon Cance... More >>r Center, Indianapolis, Indiana, 46202, United States|New York University Clinical Cancer Center, New York, New York, 10016, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States Less <<
NCT00911248 Neurofibromatosis 2 PHASE2 TERMINATED 2012-03-31 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.14mL

0.43mL

0.21mL

10.70mL

2.14mL

1.07mL

21.40mL

4.28mL

2.14mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories